Atherosclerosis is a complex and progressive cardiovascular condition that involves the gradual buildup of plaque in the arteries, restricting blood flow and potentially leading to serious health complications. This condition stems from the accumulation of cholesterol, fats, and inflammatory cells on the inner walls of arteries, forming atherosclerotic plaques. As these plaques grow, they can narrow the arteries, impeding the smooth flow of blood to vital organs and tissues. Atherosclerosis is a significant contributor to various cardiovascular diseases, including heart attacks, strokes, and peripheral artery disease. Risk factors for developing atherosclerosis include high cholesterol levels, hypertension, smoking, diabetes, and a sedentary lifestyle. Understanding the underlying mechanisms of atherosclerosis is crucial for developing effective prevention and treatment strategies. Lifestyle modifications, such as adopting a heart-healthy diet, regular exercise, and managing risk factors, play a pivotal role in mitigating the progression of atherosclerosis and promoting overall cardiovascular health. Ongoing research continues to unravel the intricacies of atherosclerosis, paving the way for innovative therapies and interventions aimed at reducing its impact on global health
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India